Atara Biotherapeutics, Inc.

US$7.87As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ATRAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (30.91%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.32
PE TTM —
TSR TTM (47.00%)
Mkt cap US$79.00M
ROIC (78.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.52
8.27%
(79.61%)
Hold 8|8|7|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.15
0.15
0.15
0.15
24.40%
11.55%
6.90%
(2.86%)
Revenue$M
3.570
3.753
3.682
3.586
4.33%
7.04%
8.13%
4.64%
Peers (US$79.00M)
Cap (US$)
PE
78.36M
—
Capital
TTM
5Y
10Y
Leveragex
0.858
0.544
0.386
EBIT/Intx
0.910
0.191
0.181
Own earn%
(59.90)
(77.84)
(73.39)
Sh yield%
29.52
33.15
35.25
Owners
Insiders/Inst%
8.33
86.75
Short interest%
0.80
SBC / revenue%
0.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
11–19
$1 testx
—
Incr. ROIC%
6